STAT Plus: With $5 billion Galapagos deal, CEO Daniel O’Day starts putting his stamp on Gilead
ERIC RISBERG/AP
Daniel O’Day was made CEO four-and-a-half months ago, charged with reigniting investor excitement in a company that pioneered HIV medicines.
No hay comentarios:
Publicar un comentario